Literature DB >> 14332054

POLYCYTHEMIA VERA: AGE RELATIONSHIPS AND SURVIVAL.

E E OSGOOD.   

Abstract

Keywords:  AGING; DIAGNOSIS; LEUKEMIA; OREGON; PHOSPHORUS ISOTOPES; POLYCYTHEMIA VERA; PROGNOSIS; RADIOTHERAPY; STATISTICS

Mesh：

Substances：

Year:  1965        PMID： 14332054

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Present status of 32P-therapy in management of polycythemia vera.

Authors:  G Meuret
Journal:  Klin Wochenschr       Date:  1975-06-15

2.  32P-therapy in polycythemia vera.

Authors:  G Meuret; G Hoffmann; R Gmelin
Journal:  Klin Wochenschr       Date:  1975-06-01

3.  Treatment of polycythemia vera.

Authors:  B K MacDougall; B H Weinerman; S Kemel
Journal:  Can Med Assoc J       Date:  1979-09-08       Impact factor: 8.262

4.  Budd-Chiari syndrome has different presentations and disease severity during adolescence.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Amit Gupte; Megha Meshram; Shobna Bhatia
Journal:  Hepatol Int       Date:  2018-07-03       Impact factor: 6.047

5.  Polycythemia vera. A clinical study of 141 patients.

Authors:  B Anger; U Haug; R Seidler; H Heimpel
Journal:  Blut       Date:  1989-12

6.  Chronic myeloproliferative disorders: prognostic importance of new working classification.

Authors:  R Burkhardt; K Jaeger; G Kettner; G Helmer
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

Review 7.  Clinical and hematological presentation of children and adolescents with polycythemia vera.

Authors:  Holger Cario; Mary Frances McMullin; Heike L Pahl
Journal:  Ann Hematol       Date:  2009-05-26       Impact factor: 3.673

8.  Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.

Authors:  Jean-Christophe Ianotto; Natalia Curto-Garcia; Marie Lauermanova; Deepti Radia; Jean-Jacques Kiladjian; Claire N Harrison
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

9.  Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).

Authors: 
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.